Manulife-S Reports Q3 Results: Core Earnings Hit C$2.1 Billion, Up 4% Year-on-Year

Stock News11-05

Manulife-S (00945) has released its financial results for the third quarter of 2026.

Core earnings came in at C$2.1 billion, representing a 4% increase compared to the third quarter of 2025 on a constant exchange rate basis. Net income attributable to shareholders was C$1.4 billion, a decrease of C$400 million from the third quarter of 2025. Core EPS stood at C$1.24, up 6% from the third quarter of 2025, while EPS was C$0.82, down 21% year-on-year. Core ROE reached 17.8%, with ROE at 11.8%. The Life Insurance Capital Adequacy Test (LICAT) ratio was 136%. APE sales, new business CSM2, and new business value5 were broadly in line with the third quarter of 2025. The Global Wealth and Asset Management business recorded net outflows of C$3.6 billion, compared to net outflows of C$6.2 billion in the third quarter of 2025.

"Our third-quarter results were strong, with core EPS reaching a new high and core ROE at 17.8%, primarily driven by double-digit growth in core earnings in Asia and significant contributions from our North American insurance operations. These results reflect our disciplined execution of the strategy we launched a year ago and demonstrate our ability to deliver sustained growth amid an uncertain market environment."

"During the quarter, we enhanced our investment and protection products to provide clients with more choices; completed the largest fundraising ever for the Comvest private credit platform under Manulife | Comvest; expanded the application of AI-enabled solutions to deliver tangible results for clients and advisors; and advanced new health and longevity solutions and partnerships. These initiatives are strengthening our competitive advantages, deepening client relationships, and creating long-term value for shareholders." — Manulife President and Chief Executive Officer Phil Witherington

"This quarter, we continued to deploy capital prudently, returning C$1.3 billion to shareholders while maintaining a robust balance sheet with a LICAT ratio of 136% and a financial leverage ratio below our medium-term target. In addition, we completed our annual review of actuarial methods and assumptions, which had an overall net favorable impact, further validating the strength of our reserves."

"While continuing to invest in growth across our businesses, we also further improved expense efficiency during the quarter. Our financial flexibility and consistent execution provide a solid foundation for continuing to create long-term value." — Manulife Chief Financial Officer Colin Simpson

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment